Participants in the clinical trial, which took place in 2008, used the drops or a placebo for four months. The short-term trial suggested that the drops gave some patients clearer vision. But the ...

They identified ophthalmic acid as an alternative neurotransmitter through detailed behavioral, biochemical, and ...

The recent approval of Vuity by the Food and Drug Administration marks a significant advancement in treating presbyopia, a ...

It may be possible one day to use lanosterol in the form of a topical eye drop to reduce cataract development. Lanosterol eye ...

An Indian pharma company has come out with a new eye drop, which purportedly helps people in their mid 40s get rid of their reading glasses. But the drug regulator DCGI has suspended the licence ...

Entod Pharmaceuticals has unveiled PresVu, India's first eye drop developed to lessen dependence ... with presbyopia and are looking for alternatives to reading glasses. According to industry ...

PresVu eye drops, developed by Entod Pharmaceuticals ... PresVu claimed to reduce or eliminate the need for these glasses, offering an alternative through its active ingredient, 1.25% Pilocarpine ...

Presbyopia has long been managed with reading glasses, contact lenses and surgical interventions, but now the eye drop offers an advanced alternative that augments near vision within 15 minutes.

Amy is a health reporter and writer with extensive experience covering health conditions, fitness, mental health, and nutrition. She also writes about outdoors and travel. In addition to Health ...

PresVu eye drops emerges as the first-of-its-kind eye drop in India designed to eliminate the need for reading glasses, said Entod CEO Nikkhil K Masurkar.(REUTERS) PresVu eye drops, developed at ...

The company claims that PresVu is the first non-invasive solution in India, offering an alternative to reading glasses by enhancing near vision. Additionally, these eye drops also serve as a ...

PresVu eye drops were being promoted as an alternative to reading glasses. The unauthorized promotion in press and over social media had raised doubt on its unsafe use by patients and safety ...